CD38 and mantle cell lymphoma: In addition, CD38 represents a marker to distinguish nodal (~94% of CD38+ cases) and non-nodal (~48% of CD38+ cases) MCL, with expression correlating with a shorter median survival in several independent series of MCL cases (120, 121).